ID   DNJA2_HUMAN             Reviewed;         412 AA.
AC   O60884; B2R7L7; O14711;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   28-JAN-2026, entry version 223.
DE   RecName: Full=DnaJ homolog subfamily A member 2;
DE   AltName: Full=Cell cycle progression restoration gene 3 protein;
DE   AltName: Full=Dnj3;
DE            Short=Dj3;
DE   AltName: Full=HIRA-interacting protein 4;
DE   AltName: Full=Renal carcinoma antigen NY-REN-14;
DE   Flags: Precursor;
GN   Name=DNAJA2; Synonyms=CPR3, HIRIP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Lorain S., Brendel C., Scamps C., Lecluse Y., Lipinski M.;
RT   "HIRIP4, a new human DnaJ, is a nuclear protein that interacts with the
RT   product of the DiGeorge syndrome gene candidate HIRA.";
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9383053; DOI=10.1093/genetics/147.3.1063;
RA   Edwards M.C., Liegeois N., Horecka J., DePinho R.A., Sprague G.F. Jr.,
RA   Tyers M., Elledge S.J.;
RT   "Human CPR (cell cycle progression restoration) genes impart a Far-
RT   phenotype on yeast cells.";
RL   Genetics 147:1063-1076(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=10816573; DOI=10.1074/jbc.m002021200;
RA   Terada K., Mori M.;
RT   "Human DnaJ homologs dj2 and dj3, and bag-1 are positive cochaperones of
RT   hsc70.";
RL   J. Biol. Chem. 275:24728-24734(2000).
RN   [8]
RP   ISOPRENYLATION AT CYS-409.
RX   PubMed=15308774; DOI=10.1073/pnas.0403413101;
RA   Kho Y., Kim S.C., Jiang C., Barma D., Kwon S.W., Cheng J., Jaunbergs J.,
RA   Weinbaum C., Tamanoi F., Falck J., Zhao Y.;
RT   "A tagging-via-substrate technology for detection and proteomics of
RT   farnesylated proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12479-12484(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION.
RX   PubMed=24318877; DOI=10.1074/jbc.m113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-391; SER-394 AND SER-395, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-134, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Co-chaperone of Hsc70. Stimulates ATP hydrolysis and the
CC       folding of unfolded proteins mediated by HSPA1A/B (in vitro)
CC       (PubMed:24318877). {ECO:0000269|PubMed:24318877}.
CC   -!- INTERACTION:
CC       O60884; Q9GZX7: AICDA; NbExp=3; IntAct=EBI-352957, EBI-3834328;
CC       O60884; Q5QP82: DCAF10; NbExp=2; IntAct=EBI-352957, EBI-723230;
CC       O60884; Q8WW22: DNAJA4; NbExp=4; IntAct=EBI-352957, EBI-2555157;
CC       O60884; P63172: DYNLT1; NbExp=3; IntAct=EBI-352957, EBI-1176455;
CC       O60884; Q9Y266: NUDC; NbExp=5; IntAct=EBI-352957, EBI-357298;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001309; CAA04669.1; -; mRNA.
DR   EMBL; Y13350; CAA73791.1; -; mRNA.
DR   EMBL; AF011793; AAB69313.1; -; mRNA.
DR   EMBL; AK313031; BAG35864.1; -; mRNA.
DR   EMBL; CH471092; EAW82693.1; -; Genomic_DNA.
DR   EMBL; BC013044; AAH13044.1; -; mRNA.
DR   EMBL; BC015809; AAH15809.1; -; mRNA.
DR   CCDS; CCDS10726.1; -.
DR   RefSeq; NP_005871.1; NM_005880.4.
DR   PDB; 7ZHS; EM; 6.90 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z/a/b/c/d=1-412.
DR   PDBsum; 7ZHS; -.
DR   AlphaFoldDB; O60884; -.
DR   EMDB; EMD-14706; -.
DR   EMDB; EMD-14727; -.
DR   EMDB; EMD-14729; -.
DR   EMDB; EMD-14736; -.
DR   SMR; O60884; -.
DR   BioGRID; 115582; 613.
DR   CORUM; O60884; -.
DR   DIP; DIP-33143N; -.
DR   FunCoup; O60884; 2216.
DR   IntAct; O60884; 328.
DR   MINT; O60884; -.
DR   STRING; 9606.ENSP00000314030; -.
DR   ChEMBL; CHEMBL4295671; -.
DR   GlyGen; O60884; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O60884; -.
DR   MetOSite; O60884; -.
DR   PhosphoSitePlus; O60884; -.
DR   SwissPalm; O60884; -.
DR   BioMuta; DNAJA2; -.
DR   CPTAC; CPTAC-496; -.
DR   CPTAC; CPTAC-497; -.
DR   jPOST; O60884; -.
DR   MassIVE; O60884; -.
DR   PaxDb; 9606-ENSP00000314030; -.
DR   PeptideAtlas; O60884; -.
DR   ProteomicsDB; 49650; -.
DR   Pumba; O60884; -.
DR   Antibodypedia; 28078; 414 antibodies from 31 providers.
DR   DNASU; 10294; -.
DR   Ensembl; ENST00000317089.10; ENSP00000314030.5; ENSG00000069345.13.
DR   GeneID; 10294; -.
DR   KEGG; hsa:10294; -.
DR   MANE-Select; ENST00000317089.10; ENSP00000314030.5; NM_005880.4; NP_005871.1.
DR   UCSC; uc002eeo.3; human.
DR   AGR; HGNC:14884; -.
DR   ClinPGx; PA27409; -.
DR   CTD; 10294; -.
DR   DisGeNET; 10294; -.
DR   GeneCards; DNAJA2; -.
DR   HGNC; HGNC:14884; DNAJA2.
DR   HPA; ENSG00000069345; Low tissue specificity.
DR   MIM; 611322; gene.
DR   OpenTargets; ENSG00000069345; -.
DR   VEuPathDB; HostDB:ENSG00000069345; -.
DR   eggNOG; KOG0712; Eukaryota.
DR   GeneTree; ENSGT00940000154688; -.
DR   HOGENOM; CLU_017633_10_0_1; -.
DR   InParanoid; O60884; -.
DR   OMA; RVCPTCV; -.
DR   OrthoDB; 550424at2759; -.
DR   PAN-GO; O60884; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; O60884; -.
DR   PathwayCommons; O60884; -.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   SignaLink; O60884; -.
DR   Agora; ENSG00000069345; -.
DR   BioGRID-ORCS; 10294; 31 hits in 1157 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; DNAJA2; human.
DR   GeneWiki; DNAJA2; -.
DR   GenomeRNAi; 10294; -.
DR   Pharos; O60884; Tbio.
DR   PRO; PR:O60884; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; O60884; protein.
DR   Bgee; ENSG00000069345; Expressed in calcaneal tendon and 208 other cell types or tissues.
DR   ExpressionAtlas; O60884; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0001671; F:ATPase activator activity; IDA:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IEA:InterPro.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IPI:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0009408; P:response to heat; IEA:InterPro.
DR   CDD; cd06257; DnaJ; 1.
DR   CDD; cd10747; DnaJ_C; 1.
DR   CDD; cd10719; DnaJ_zf; 1.
DR   FunFam; 2.60.260.20:FF:000068; Chaperone protein dnaJ 3; 1.
DR   FunFam; 1.10.287.110:FF:000016; DnaJ (Hsp40) homolog, subfamily A, member 2; 1.
DR   FunFam; 2.10.230.10:FF:000005; DnaJ homolog subfamily A member 1; 1.
DR   FunFam; 2.60.260.20:FF:000003; DnaJ subfamily A member 2; 1.
DR   Gene3D; 1.10.287.110; DnaJ domain; 1.
DR   Gene3D; 2.10.230.10; Heat shock protein DnaJ, cysteine-rich domain; 1.
DR   Gene3D; 2.60.260.20; Urease metallochaperone UreE, N-terminal domain; 2.
DR   HAMAP; MF_01152; DnaJ; 1.
DR   InterPro; IPR012724; DnaJ.
DR   InterPro; IPR002939; DnaJ_C.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR044713; DNJA1/2-like.
DR   InterPro; IPR008971; HSP40/DnaJ_pept-bd.
DR   InterPro; IPR001305; HSP_DnaJ_Cys-rich_dom.
DR   InterPro; IPR036410; HSP_DnaJ_Cys-rich_dom_sf.
DR   InterPro; IPR036869; J_dom_sf.
DR   PANTHER; PTHR43888; DNAJ-LIKE-2, ISOFORM A-RELATED; 1.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF01556; DnaJ_C; 1.
DR   Pfam; PF00684; DnaJ_CXXCXGXG; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; Chaperone J-domain; 1.
DR   SUPFAM; SSF57938; DnaJ/Hsp40 cysteine-rich domain; 1.
DR   SUPFAM; SSF49493; HSP40/DnaJ peptide-binding domain; 2.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS51188; ZF_CR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chaperone; Isopeptide bond; Lipoprotein;
KW   Membrane; Metal-binding; Methylation; Phosphoprotein; Prenylation;
KW   Proteomics identification; Reference proteome; Repeat; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..409
FT                   /note="DnaJ homolog subfamily A member 2"
FT                   /id="PRO_0000071011"
FT   PROPEP          410..412
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000393942"
FT   DOMAIN          8..70
FT                   /note="J"
FT   REPEAT          143..150
FT                   /note="CXXCXGXG motif"
FT   REPEAT          159..166
FT                   /note="CXXCXGXG motif"
FT   REPEAT          186..193
FT                   /note="CXXCXGXG motif"
FT   REPEAT          202..209
FT                   /note="CXXCXGXG motif"
FT   ZN_FING         130..214
FT                   /note="CR-type"
FT   REGION          365..412
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         143
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         146
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         159
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         162
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         186
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         189
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         202
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         205
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         39
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QYJ0"
FT   MOD_RES         78
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35824"
FT   MOD_RES         152
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QYJ0"
FT   MOD_RES         391
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         409
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000305"
FT   LIPID           409
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:15308774"
FT   CROSSLNK        134
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CONFLICT        17
FT                   /note="P -> A (in Ref. 2; AAB69313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        42..46
FT                   /note="NAGDK -> QMQETN (in Ref. 2; AAB69313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83..93
FT                   /note="GMDDIFSHIFG -> WHGLIFSLTVFC (in Ref. 2; AAB69313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        242..257
FT                   /note="GVEPGDIVLLLQEKEH -> EWNPETLFFLLPGEKNM (in Ref. 2;
FT                   AAB69313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286..287
FT                   /note="FK -> LS (in Ref. 2; AAB69313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        328
FT                   /note="D -> G (in Ref. 2; AAB69313)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   412 AA;  45746 MW;  8F1BC367425CB428 CRC64;
     MANVADTKLY DILGVPPGAS ENELKKAYRK LAKEYHPDKN PNAGDKFKEI SFAYEVLSNP
     EKRELYDRYG EQGLREGSGG GGGMDDIFSH IFGGGLFGFM GNQSRSRNGR RRGEDMMHPL
     KVSLEDLYNG KTTKLQLSKN VLCSACSGQG GKSGAVQKCS ACRGRGVRIM IRQLAPGMVQ
     QMQSVCSDCN GEGEVINEKD RCKKCEGKKV IKEVKILEVH VDKGMKHGQR ITFTGEADQA
     PGVEPGDIVL LLQEKEHEVF QRDGNDLHMT YKIGLVEALC GFQFTFKHLD GRQIVVKYPP
     GKVIEPGCVR VVRGEGMPQY RNPFEKGDLY IKFDVQFPEN NWINPDKLSE LEDLLPSRPE
     VPNIIGETEE VELQEFDSTR GSGGGQRREA YNDSSDEESS SHHGPGVQCA HQ
//
